Leonard Post

Insider Reports History

Entity
Individual
Location
C/O Cg Oncology, Inc., 400 Spectrum Drive Suite 2040, Irvine, CA
Signature
/s/ Joshua F. Patterson, Attorney-in-Fact for Leonard Post
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Leonard Post:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Fulgent Genetics, Inc. Director Common Stock 8K $214K $26.69 Aug 1, 2022 Direct
uniQure N.V. Director Ordinary Shares 24.1K $116K $4.81 Jun 19, 2024 Direct
uniQure N.V. Director Stock Option (Right to Buy) 15.8K Jun 19, 2024 Direct
CG Oncology, Inc. Director Stock Option (Right to Buy) 15.6K Oct 4, 2024 Direct

Insider Reports Filed by Leonard Post

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CGON CG Oncology, Inc. Oct 4, 2024 1 $0 4 Oct 7, 2024 Director
QURE uniQure N.V. Jun 19, 2024 2 $0 4 Jun 21, 2024 Director
QURE uniQure N.V. Jun 13, 2024 1 -$11.4K 4 Jun 18, 2024 Director
CGON CG Oncology, Inc. Jan 24, 2024 0 $0 3 Jan 24, 2024 Director
QURE uniQure N.V. Jun 13, 2023 3 -$43.1K 4 Jun 20, 2023 Director
QURE uniQure N.V. Feb 27, 2023 1 -$7.67K 4 Mar 1, 2023 Director
FLGT Fulgent Genetics, Inc. Aug 1, 2022 1 $0 4 Aug 3, 2022 Director
FLGT Fulgent Genetics, Inc. Aug 1, 2022 0 $0 3 Aug 3, 2022 Director
QURE uniQure N.V. Jun 15, 2022 2 $0 4 Jun 17, 2022 Director
QURE uniQure N.V. Feb 28, 2022 1 -$13.2K 4 Mar 2, 2022 Director
QURE uniQure N.V. Feb 24, 2022 2 $0 4 Feb 28, 2022 Director